Lucid Diagnostics Ownership 2024 | Who Owns Lucid Diagnostics Now?


OverviewForecastRevenueFinancialsChartTranscripts

Institutional Ownership

4.28%

Insider Ownership

65.04%

Retail Ownership

30.69%

Institutional Holders

30.00

Lucid Diagnostics Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
LUMINUS MANAGEMENT LLC1.61%0.34%725,8258,1681.14%595,177Jun 30, 2024
VANGUARD GROUP INC1.25%-560,915--459,950Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC0.45%-204,35548,59831.20%167,590Jun 30, 2024
NANTAHALA CAPITAL MANAGEMENT, LLC0.28%0.01%126,362-23,336-15.59%103,617Jun 30, 2024
LIDO ADVISORS, LLC0.15%0.00%68,01668,016100.00%55,773Jun 30, 2024
LPL FINANCIAL LLC0.09%-41,4574,42511.95%33,995Jun 30, 2024
VERITION FUND MANAGEMENT LLC0.09%0.00%39,711-2,668-6.30%32,563Jun 30, 2024
GENEOS WEALTH MANAGEMENT INC.0.08%0.00%33,850--27,757Jun 30, 2024
TWO SIGMA SECURITIES, LLC0.06%0.00%27,75327,753100.00%22,757Jun 30, 2024
BLACKROCK INC.0.06%-27,310-24,336-47.12%22,394Jun 30, 2024
STATE STREET CORP0.06%-26,9818,55346.41%22,124,000Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)0.04%0.00%19,798-175-0.88%16,234Jun 30, 2024
AXIOM ADVISORY, LLC0.03%0.00%14,95814,958100.00%12,861Jun 30, 2024
VIRTU FINANCIAL LLC0.03%0.00%14,158-20,513-59.16%12,000Jun 30, 2024
RESOURCES INVESTMENT ADVISORS, LLC.0.03%0.00%13,53013,530100.00%11,095Jun 30, 2024
NORTHERN TRUST CORP0.03%-13,128-17-0.13%10,765,000Jun 30, 2024
FIRST MANHATTAN CO. LLC.0.03%-12,60012,600100.00%10,332Jun 30, 2024
BYRNE ASSET MANAGEMENT LLC0.02%0.01%11,00011,000100.00%9,559Jun 30, 2024
JONES FINANCIAL COMPANIES LLLP0.01%-3,831--3,141Jun 30, 2024
WELLS FARGO & COMPANY/MN0.01%-3,463-11,042-76.13%2,840Jun 30, 2024

Lucid Diagnostics's largest institutional shareholder is LUMINUS MANAGEMENT LLC, holding 1.61% of the company's total share outstanding, currently valued at $595.18K. The top 10 institutional shareholders own together 4.12% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
LUMINUS MANAGEMENT LLC1.61%0.34%725,8258,1681.14%595,177Jun 30, 2024
BYRNE ASSET MANAGEMENT LLC0.02%0.01%11,00011,000100.00%9,559Jun 30, 2024
NANTAHALA CAPITAL MANAGEMENT, LLC0.28%0.01%126,362-23,336-15.59%103,617Jun 30, 2024
GENEOS WEALTH MANAGEMENT INC.0.08%0.00%33,850--27,757Jun 30, 2024
VIRTU FINANCIAL LLC0.03%0.00%14,158-20,513-59.16%12,000Jun 30, 2024
LIDO ADVISORS, LLC0.15%0.00%68,01668,016100.00%55,773Jun 30, 2024
TWO SIGMA SECURITIES, LLC0.06%0.00%27,75327,753100.00%22,757Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)0.04%0.00%19,798-175-0.88%16,234Jun 30, 2024
VERITION FUND MANAGEMENT LLC0.09%0.00%39,711-2,668-6.30%32,563Jun 30, 2024
AXIOM ADVISORY, LLC0.03%0.00%14,95814,958100.00%12,861Jun 30, 2024
RESOURCES INVESTMENT ADVISORS, LLC.0.03%0.00%13,53013,530100.00%11,095Jun 30, 2024
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC0.00%0.00%1,0001,000100.00%820Jun 30, 2024
FIRST MANHATTAN CO. LLC.0.03%-12,60012,600100.00%10,332Jun 30, 2024
LPL FINANCIAL LLC0.09%-41,4574,42511.95%33,995Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC0.45%-204,35548,59831.20%167,590Jun 30, 2024
VANGUARD GROUP INC1.25%-560,915--459,950Jun 30, 2024
M&R CAPITAL MANAGEMENT INC0.00%-25--21,000Jun 30, 2024
CWM, LLC0.00%-1,761--1,000Jun 30, 2024
JONES FINANCIAL COMPANIES LLLP0.01%-3,831--3,141Jun 30, 2024
NORTHERN TRUST CORP0.03%-13,128-17-0.13%10,765,000Jun 30, 2024

The largest Lucid Diagnostics shareholder by % of total assets is LUMINUS MANAGEMENT LLC. The company owns 725.83K shares of Lucid Diagnostics (LUCD), representing 0.34% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
LIDO ADVISORS, LLC0.15%0.00%68,01668,016100.00%55,773Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC0.45%-204,35548,59831.20%167,590Jun 30, 2024
TWO SIGMA SECURITIES, LLC0.06%0.00%27,75327,753100.00%22,757Jun 30, 2024
AXIOM ADVISORY, LLC0.03%0.00%14,95814,958100.00%12,861Jun 30, 2024
RESOURCES INVESTMENT ADVISORS, LLC.0.03%0.00%13,53013,530100.00%11,095Jun 30, 2024
FIRST MANHATTAN CO. LLC.0.03%-12,60012,600100.00%10,332Jun 30, 2024
BYRNE ASSET MANAGEMENT LLC0.02%0.01%11,00011,000100.00%9,559Jun 30, 2024
STATE STREET CORP0.06%-26,9818,55346.41%22,124,000Jun 30, 2024
LUMINUS MANAGEMENT LLC1.61%0.34%725,8258,1681.14%595,177Jun 30, 2024
LPL FINANCIAL LLC0.09%-41,4574,42511.95%33,995Jun 30, 2024
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC0.00%0.00%1,0001,000100.00%820Jun 30, 2024
BANK OF AMERICA CORP /DE/0.00%-1741715700.00%143Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD0.00%-10310210200.00%85Jun 30, 2024
JPMORGAN CHASE & CO0.00%-501647.06%41Jun 30, 2024
NEWEDGE ADVISORS, LLC--22100.00%2Jun 30, 2024
THOMPSON INVESTMENT MANAGEMENT, INC.--1--1Jun 30, 2024
CIBC PRIVATE WEALTH GROUP, LLC0.00%-315--259Jun 30, 2024
ALLWORTH FINANCIAL LP0.00%-157--132Jun 30, 2024
JONES FINANCIAL COMPANIES LLLP0.01%-3,831--3,141Jun 30, 2024
CWM, LLC0.00%-1,761--1,000Jun 30, 2024

As of Jun 30 2024, Lucid Diagnostics's largest institutional buyer is LIDO ADVISORS, LLC. The company purchased 68.02K stocks of LUCD, valued at $55.77K.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
HRT FINANCIAL LP----63,035-100.00%-Jun 30, 2024
BLACKROCK INC.0.06%-27,310-24,336-47.12%22,394Jun 30, 2024
NANTAHALA CAPITAL MANAGEMENT, LLC0.28%0.01%126,362-23,336-15.59%103,617Jun 30, 2024
VIRTU FINANCIAL LLC0.03%0.00%14,158-20,513-59.16%12,000Jun 30, 2024
WELLS FARGO & COMPANY/MN0.01%-3,463-11,042-76.13%2,840Jun 30, 2024
VERITION FUND MANAGEMENT LLC0.09%0.00%39,711-2,668-6.30%32,563Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)0.04%0.00%19,798-175-0.88%16,234Jun 30, 2024
MORGAN STANLEY0.00%-954-22-2.25%782Jun 30, 2024
NORTHERN TRUST CORP0.03%-13,128-17-0.13%10,765,000Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.0.00%-42-3-6.67%33Jun 30, 2024
GENEOS WEALTH MANAGEMENT INC.0.08%0.00%33,850--27,757Jun 30, 2024
VANGUARD GROUP INC1.25%-560,915--459,950Jun 30, 2024
M&R CAPITAL MANAGEMENT INC0.00%-25--21,000Jun 30, 2024
CWM, LLC0.00%-1,761--1,000Jun 30, 2024
JONES FINANCIAL COMPANIES LLLP0.01%-3,831--3,141Jun 30, 2024
ALLWORTH FINANCIAL LP0.00%-157--132Jun 30, 2024
CIBC PRIVATE WEALTH GROUP, LLC0.00%-315--259Jun 30, 2024
THOMPSON INVESTMENT MANAGEMENT, INC.--1--1Jun 30, 2024
NEWEDGE ADVISORS, LLC--22100.00%2Jun 30, 2024
JPMORGAN CHASE & CO0.00%-501647.06%41Jun 30, 2024

As of Jun 30 2024, Lucid Diagnostics's biggest institutional seller is HRT FINANCIAL LP. The company sold -63.03K shares of LUCD, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
LIDO ADVISORS, LLC0.15%0.00%68,01668,016100.00%55,773Jun 30, 2024
TWO SIGMA SECURITIES, LLC0.06%0.00%27,75327,753100.00%22,757Jun 30, 2024
AXIOM ADVISORY, LLC0.03%0.00%14,95814,958100.00%12,861Jun 30, 2024
RESOURCES INVESTMENT ADVISORS, LLC.0.03%0.00%13,53013,530100.00%11,095Jun 30, 2024
FIRST MANHATTAN CO. LLC.0.03%-12,60012,600100.00%10,332Jun 30, 2024
NEWEDGE ADVISORS, LLC--22100.00%2Jun 30, 2024

Lucid Diagnostics's largest new institutional shareholder by number of shares is LIDO ADVISORS, LLC, purchased 68.02K shares, valued at $55.77K, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
HRT FINANCIAL LP----63,035-100.00%-Jun 30, 2024

Lucid Diagnostics's largest sold out institutional shareholder by shares sold is HRT FINANCIAL LP, sold -63.03K shares, valued at -, as of undefined.

Lucid Diagnostics Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
BRIDGEWAY FUNDS INC0.06%135,000--Mar 28, 2024
BUFFALO FUNDS0.02%133,000--Mar 31, 2024
VANGUARD INDEX FUNDS0.00%560,915182,39948.19%Mar 31, 2024
PUTNAM FUNDS TRUST0.00%230,480--Jan 31, 2024
FIDELITY CONCORD STREET TRUST0.00%152,55321,93716.80%Feb 29, 2024
PUTNAM VARIABLE TRUST0.00%11,492--Mar 31, 2024
Calvert Variable Products, Inc.0.00%390--Mar 31, 2024
SCHWAB CAPITAL TRUST0.00%1,998-8,915-81.69%Jan 31, 2024
Global X Funds0.00%1,492--Jan 31, 2024
NORTHERN FUNDS0.00%2,598--Mar 28, 2024
FIDELITY SALEM STREET TRUST0.00%47,374--Mar 31, 2024
NATIONWIDE VARIABLE INSURANCE TRUST0.00%1,546--Mar 31, 2024
ProFunds0.00%108--Mar 31, 2024
VANGUARD SCOTTSDALE FUNDS0.00%17,361--Feb 29, 2024
RYDEX SERIES FUNDS0.00%30--Dec 31, 2023
T. Rowe Price Index Trust, Inc.0.00%151--Feb 29, 2024
VALIC Co I0.00%1,870--Feb 29, 2024
Guggenheim Active Allocation Fund0.00%391034.48%Feb 29, 2024
RYDEX DYNAMIC FUNDS0.00%26--Dec 31, 2023
USAA MUTUAL FUNDS TRUST0.00%831--Jan 31, 2024
RYDEX VARIABLE TRUST0.00%4--Dec 31, 2023
PROSHARES TRUST0.00%719--Feb 29, 2024
ETF Series Solutions0.00%32--Jan 31, 2024
SUNAMERICA SERIES TRUST0.00%556--Mar 31, 2024
iSHARES TRUST0.00%21,823-576-2.57%Mar 31, 2024
EQ ADVISORS TRUST0.00%1,57752349.62%Mar 31, 2024
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST0.00%2,000--Mar 31, 2024
MASSMUTUAL SELECT FUNDS0.00%508--Dec 31, 2023
PACIFIC SELECT FUND0.00%1,043--Mar 31, 2024
COLLEGE RETIREMENT EQUITIES FUND0.00%241--Mar 31, 2024
Bridge Builder Trust0.00%890--Mar 31, 2024
PRINCIPAL FUNDS, INC.0.00%761--Feb 29, 2024

Lucid Diagnostics's largest mutual fund holder by % of total assets is "BRIDGEWAY FUNDS INC", owning 135.00K shares, compromising 0.06% of its total assets.

Lucid Diagnostics Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 24307.14%
31 Mar, 242816.67%
31 Dec, 23244.35%
30 Sep, 232343.75%
30 Jun, 2316-11.11%
31 Mar, 2318-18.18%
31 Dec, 222210.00%
30 Sep, 2220-16.67%
30 Jun, 2224-25.00%
31 Mar, 2232-8.57%
31 Dec, 2135-

As of 30 Jun 24, 30 institutions are holding Lucid Diagnostics's shares, representing an increase of 7.14% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 241,925,567-7.03%
31 Mar, 242,071,20418.45%
31 Dec, 231,748,600-8.70%
30 Sep, 231,915,1592.76%
30 Jun, 231,863,7435.39%
31 Mar, 231,768,504-7.69%
31 Dec, 221,915,916-16.84%
30 Sep, 222,303,833-6.21%
30 Jun, 222,456,415-9.25%
31 Mar, 222,706,929-18.20%
31 Dec, 213,309,147-

Lucid Diagnostics (LUCD) has 1.93M shares outstanding as of 30 Jun 24, down -7.03% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 244.28%17.39%
31 Mar, 244.96%28.43%
31 Dec, 234.18%19.93%
30 Sep, 234.58%22.12%
30 Jun, 234.55%24.42%
31 Mar, 234.32%15.39%
31 Dec, 225.30%13.23%
30 Sep, 226.33%13.41%
30 Jun, 226.87%11.56%
31 Mar, 227.71%2.44%
31 Dec, 2117.79%-

As of 30 Jun 24, Lucid Diagnostics is held by 4.28% institutional shareholders, representing a 17.39% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 2413-35.00%
31 Mar, 2420150.00%
31 Dec, 238-27.27%
30 Sep, 231183.33%
30 Jun, 236-14.29%
31 Mar, 237-22.22%
31 Dec, 22912.50%
30 Sep, 228-38.46%
30 Jun, 2213-7.14%
31 Mar, 2214-60.00%
31 Dec, 2135-

13 institutional shareholders have increased their position in LUCD stock as of 30 Jun 24 compared to 20 in the previous quarter (a -35.00% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 24950.00%
31 Mar, 246-25.00%
31 Dec, 23860.00%
30 Sep, 23525.00%
30 Jun, 23433.33%
31 Mar, 233-66.67%
31 Dec, 22928.57%
30 Sep, 227-12.50%
30 Jun, 228-33.33%
31 Mar, 2212-
31 Dec, 21--

9 institutional shareholders have reduced their position in LUCD stock as of 30 Jun 24 compared to 6 in the previous quarter (a 50.00% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 24307.14%1,925,567-7.03%4.28%17.39%13-35.00%950.00%
31 Mar, 242816.67%2,071,20418.45%4.96%28.43%20150.00%6-25.00%
31 Dec, 23244.35%1,748,600-8.70%4.18%19.93%8-27.27%860.00%
30 Sep, 232343.75%1,915,1592.76%4.58%22.12%1183.33%525.00%
30 Jun, 2316-11.11%1,863,7435.39%4.55%24.42%6-14.29%433.33%
31 Mar, 2318-18.18%1,768,504-7.69%4.32%15.39%7-22.22%3-66.67%
31 Dec, 222210.00%1,915,916-16.84%5.30%13.23%912.50%928.57%
30 Sep, 2220-16.67%2,303,833-6.21%6.33%13.41%8-38.46%7-12.50%
30 Jun, 2224-25.00%2,456,415-9.25%6.87%11.56%13-7.14%8-33.33%
31 Mar, 2232-8.57%2,706,929-18.20%7.71%2.44%14-60.00%12-
31 Dec, 2135-3,309,147-17.79%-35---

Lucid Diagnostics Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Sep 27, 2023Lapidus Stanleydirector-S-SaleSell200$1.43$286.00131,339
Sep 27, 2023Lapidus Stanleydirector-S-SaleSell10,000$1.47$14.74K121,339
Sep 27, 2023Lapidus Stanleydirector-S-SaleSell10,000$1.43$14.30K111,339
Sep 27, 2023Lapidus Stanleydirector-S-SaleSell9,747$1.45$14.13K101,592
Sep 27, 2023Lapidus Stanleydirector-S-SaleSell3,405$1.45$4.94K132,051
Sep 27, 2023Lapidus Stanleydirector-S-SaleSell412$1.44$593.28131,639
Sep 27, 2023Lapidus Stanleydirector-S-SaleSell100$1.44$144.00131,539

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 09, 2024Matheis Dennisdirector-Sell---49,925
Feb 20, 2024PAVmed Inc.10 percent owner-J-OtherSell3,331,747--31,302,444
Sep 27, 2023Lapidus Stanleydirector-S-SaleSell200$1.43$286.00131,339
Sep 27, 2023Lapidus Stanleydirector-S-SaleSell10,000$1.47$14.74K121,339
Sep 27, 2023Lapidus Stanleydirector-S-SaleSell10,000$1.43$14.30K111,339
Sep 27, 2023Lapidus Stanleydirector-S-SaleSell9,747$1.45$14.13K101,592
Sep 27, 2023Lapidus Stanleydirector-S-SaleSell3,405$1.45$4.94K132,051
Sep 27, 2023Lapidus Stanleydirector-S-SaleSell412$1.44$593.28131,639
Sep 27, 2023Lapidus Stanleydirector-S-SaleSell100$1.44$144.00131,539

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 09, 2024Matheis Dennisdirector-A-AwardBuy241,500$1.03$248.75K241,500
May 09, 2024Matheis Dennisdirector-Sell---49,925
May 08, 2024Gordon Michael Adamofficer General Counsel and SecretaryA-AwardBuy400,000--400,000
May 08, 2024O'Neil Shaunofficer President and COOA-AwardBuy400,000--526,763
May 08, 2024MCGRATH DENNIS Mofficer Chief Financial OfficerA-AwardBuy400,000--1,043,569
May 08, 2024Aklog Lishandirector, officer Chief Executive OfficerA-AwardBuy400,000--1,166,627
Feb 23, 2024White Debradirector-A-AwardBuy150,000$1.23$184.50K150,000
Feb 23, 2024Sparks Ronald Mdirector-A-AwardBuy150,000$1.23$184.50K150,000
Feb 23, 2024Lapidus Stanleydirector-A-AwardBuy150,000$1.23$184.50K150,000
Feb 23, 2024Cox James Ldirector-A-AwardBuy150,000$1.23$184.50K150,000
Feb 23, 2024SOKOLOV JACQUE Jdirector-A-AwardBuy150,000$1.23$184.50K150,000
Feb 20, 2024PAVmed Inc.10 percent owner-J-OtherSell3,331,747--31,302,444
Jan 30, 2024PAVmed Inc.10 percent owner-J-OtherBuy3,331,771$1.40$4.68M34,634,191
Sep 27, 2023Lapidus Stanleydirector-S-SaleSell200$1.43$286.00131,339
Sep 27, 2023Lapidus Stanleydirector-S-SaleSell10,000$1.47$14.74K121,339
Sep 27, 2023Lapidus Stanleydirector-S-SaleSell10,000$1.43$14.30K111,339
Sep 27, 2023Lapidus Stanleydirector-S-SaleSell9,747$1.45$14.13K101,592
Sep 27, 2023Lapidus Stanleydirector-S-SaleSell3,405$1.45$4.94K132,051
Sep 27, 2023Lapidus Stanleydirector-S-SaleSell412$1.44$593.28131,639
Sep 27, 2023Lapidus Stanleydirector-S-SaleSell100$1.44$144.00131,539

The last insider sell of Lucid Diagnostics's stock was made by Matheis Dennis on May 09 2024, selling - shares at - per share (valued at -).

Lucid Diagnostics Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 202451500.00%
Q1 202461600.00%
Q3 2023-10-
Q1 20235--
Q4 202210--
Q3 20221250.00%
Q2 20221--
Q1 202292450.00%
Q4 20212825.00%

5 total buy trades, and 1 total sell trades (buy/sell ratio of 5.00%) were made by Lucid Diagnostics's insiders, as of Q2 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024---
Q1 2024---
Q3 2023-10-
Q1 2023---
Q4 2022---
Q3 2022-2-
Q2 2022---
Q1 2022---
Q4 20211--

As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Lucid Diagnostics's stocks.

Lucid Diagnostics Peer Ownership


TickerCompany
FNAParagon 28, Inc.
IRMDIRadimed Corporation
OFIXOrthofix Medical Inc.
ITGRInteger Holdings Corporation
LUNGPulmonx Corporation
CLPTClearPoint Neuro, Inc.
NPCENeuroPace, Inc.
SRDXSurmodics, Inc.
LIVNLivaNova PLC
KIDSOrthoPediatrics Corp.
OSAProSomnus, Inc. Common Stock
XAIRBeyond Air, Inc.
NARIInari Medical, Inc.
CVRXCVRx, Inc.

LUCD Ownership FAQ


Lucid Diagnostics is owned by institutional shareholders (4.28%), insiders (65.04%), and public (30.69%). The largest institutional shareholder of Lucid Diagnostics is LUMINUS MANAGEMENT LLC (1.61% of total shares) and the top mutual fund owner is BRIDGEWAY FUNDS INC (0.06% of total shares).

Lucid Diagnostics's major institutional shareholders are LUMINUS MANAGEMENT LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, NANTAHALA CAPITAL MANAGEMENT, LLC, and LIDO ADVISORS, LLC. The top five shareholders own together 3.74% of the company's share outstanding.

As of Jun 2024, there are 30 institutional shareholders of Lucid Diagnostics.

LUMINUS MANAGEMENT LLC owns 725.82K shares of Lucid Diagnostics, representing 1.61% of the company's total shares outstanding, valued at $595.18K (as of Jun 2024).

As of Jun 2024, VANGUARD GROUP INC holds 560.92K shares of Lucid Diagnostics (LUCD), compromising 1.25% of the company, valued at $459.95K.

GEODE CAPITAL MANAGEMENT, LLC is the third largest holder of Lucid Diagnostics. The company owns 204.36K of the company's shares outstanding (worth $167.59K).